FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054887147> ?p ?o ?g. }

• W2054887147 endingPage "190" @default.
• W2054887147 startingPage "183" @default.
• W2054887147 abstract "Diversion—patients who sell or share their medication—is a hotly debated but relatively unresearched phenomenon. We have investigated the prevalence of self-reported diversion of methadone and buprenorphine at OST programs in Sweden. We have also examined if demographic, treatment, and social factors can be associated with an increased risk of diversion. Structured interviews were conducted with 411 patients from eleven OST programs. A standardized questionnaire with 106 close- and five open-ended questions were used. 280 interviews were done on site, by the researchers, while 131 interviews were conducted by specially trained patients through privileged access interviewing. The data were analyzed through frequency- and averages-calculations, cross-tabulations, and logistic regression analysis. In total, 24.1% (n = 99) of the patients reported diversion in the past month. 67.6% (n = 277) stated that they had diverted at some point. The peer interviews showed significantly higher levels of diversion (37.4% past month) compared with the researcher interviews (17.2%). Neither demographic factors, dosages, nor collection routines were associated with diversion. The likelihood of diversion was higher for patients on mono-buprenorphine (OR = 5.64) and buprenorphine–naloxone (OR = 2.10), than among methadone patients. Other factors which increased the likelihood of diversion were current illicit drug use (OR = 5.60), having had patients as a primary source of illicit methadone or buprenorphine prior to treatment (OR = 3.39), and mainly socializing with active drug users (OR = 2.12). Self-reported diversion was considerably higher than in previous studies. This is most likely due to the new methodological strategy we used, but may also partly be explained by low availability of OST in Sweden, leading to a high demand for the substances by heroin users outside treatment. Efforts to decrease diversion should primarily focus on psychosocial and lifestyle-changing interventions, and expanded access to treatment, rather than on control measures." @default.
• W2054887147 created "2016-06-24" @default.
• W2054887147 creator A5069533911 @default.
• W2054887147 creator A5076320165 @default.
• W2054887147 date "2015-02-01" @default.
• W2054887147 modified "2023-10-18" @default.
• W2054887147 title "Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: Prevalence estimates and risk factors" @default.
• W2054887147 cites W1520299800 @default.
• W2054887147 cites W1923689435 @default.
• W2054887147 cites W192906252 @default.
• W2054887147 cites W1945902054 @default.
• W2054887147 cites W1964555525 @default.
• W2054887147 cites W1974518105 @default.
• W2054887147 cites W1982572382 @default.
• W2054887147 cites W1990741769 @default.
• W2054887147 cites W1993880051 @default.
• W2054887147 cites W1994149607 @default.
• W2054887147 cites W1995265193 @default.
• W2054887147 cites W1995834570 @default.
• W2054887147 cites W1996258593 @default.
• W2054887147 cites W2015070588 @default.
• W2054887147 cites W2030503441 @default.
• W2054887147 cites W2031176986 @default.
• W2054887147 cites W2050115902 @default.
• W2054887147 cites W2052831258 @default.
• W2054887147 cites W2058679789 @default.
• W2054887147 cites W2061639342 @default.
• W2054887147 cites W2069047072 @default.
• W2054887147 cites W2083571912 @default.
• W2054887147 cites W2092744320 @default.
• W2054887147 cites W2096868511 @default.
• W2054887147 cites W2097042779 @default.
• W2054887147 cites W2101835013 @default.
• W2054887147 cites W2104235909 @default.
• W2054887147 cites W2110050260 @default.
• W2054887147 cites W2113698968 @default.
• W2054887147 cites W2116782439 @default.
• W2054887147 cites W2119070466 @default.
• W2054887147 cites W2129066911 @default.
• W2054887147 cites W2140711438 @default.
• W2054887147 cites W2141561600 @default.
• W2054887147 cites W2144776865 @default.
• W2054887147 cites W2150934525 @default.
• W2054887147 cites W2152118971 @default.
• W2054887147 cites W2152591738 @default.
• W2054887147 cites W2160217220 @default.
• W2054887147 cites W2161457323 @default.
• W2054887147 cites W2337690520 @default.
• W2054887147 doi "https://doi.org/10.1016/j.drugpo.2014.10.003" @default.
• W2054887147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25465344" @default.
• W2054887147 hasPublicationYear "2015" @default.
• W2054887147 type Work @default.
• W2054887147 sameAs 2054887147 @default.
• W2054887147 citedByCount "40" @default.
• W2054887147 countsByYear W20548871472015 @default.
• W2054887147 countsByYear W20548871472016 @default.
• W2054887147 countsByYear W20548871472017 @default.
• W2054887147 countsByYear W20548871472018 @default.
• W2054887147 countsByYear W20548871472019 @default.
• W2054887147 countsByYear W20548871472020 @default.
• W2054887147 countsByYear W20548871472021 @default.
• W2054887147 countsByYear W20548871472022 @default.
• W2054887147 countsByYear W20548871472023 @default.
• W2054887147 crossrefType "journal-article" @default.
• W2054887147 hasAuthorship W2054887147A5069533911 @default.
• W2054887147 hasAuthorship W2054887147A5076320165 @default.
• W2054887147 hasBestOaLocation W20548871472 @default.
• W2054887147 hasConcept C118552586 @default.
• W2054887147 hasConcept C126322002 @default.
• W2054887147 hasConcept C144024400 @default.
• W2054887147 hasConcept C149923435 @default.
• W2054887147 hasConcept C151956035 @default.
• W2054887147 hasConcept C170493617 @default.
• W2054887147 hasConcept C17744445 @default.
• W2054887147 hasConcept C199539241 @default.
• W2054887147 hasConcept C24845683 @default.
• W2054887147 hasConcept C2778750930 @default.
• W2054887147 hasConcept C2778767360 @default.
• W2054887147 hasConcept C2778949969 @default.
• W2054887147 hasConcept C2781063702 @default.
• W2054887147 hasConcept C512399662 @default.
• W2054887147 hasConcept C71924100 @default.
• W2054887147 hasConceptScore W2054887147C118552586 @default.
• W2054887147 hasConceptScore W2054887147C126322002 @default.
• W2054887147 hasConceptScore W2054887147C144024400 @default.
• W2054887147 hasConceptScore W2054887147C149923435 @default.
• W2054887147 hasConceptScore W2054887147C151956035 @default.
• W2054887147 hasConceptScore W2054887147C170493617 @default.
• W2054887147 hasConceptScore W2054887147C17744445 @default.
• W2054887147 hasConceptScore W2054887147C199539241 @default.
• W2054887147 hasConceptScore W2054887147C24845683 @default.
• W2054887147 hasConceptScore W2054887147C2778750930 @default.
• W2054887147 hasConceptScore W2054887147C2778767360 @default.
• W2054887147 hasConceptScore W2054887147C2778949969 @default.
• W2054887147 hasConceptScore W2054887147C2781063702 @default.
• W2054887147 hasConceptScore W2054887147C512399662 @default.
• W2054887147 hasConceptScore W2054887147C71924100 @default.
• W2054887147 hasFunder F4320324004 @default.

• next